US 8372872
Methods for concomitant treatment of theophylline and febuxostat
granted A61KA61K31/415A61K31/426
Quick answer
US patent 8372872 (Methods for concomitant treatment of theophylline and febuxostat) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/415, A61K31/426, A61K31/522, A61K45/06